
More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

Covid-19 has sped up the adoption of artificial intelligence in the life sciences and healthcare, but business leaders are confident in its effectiveness, report finds

Raises projected supply of one-dose shot to 200 million

Company’s rebranded platform, Ocellos, will manage complex handoffs in cell and gene therapy (CGT) treatments and trials

Puts packaging business on pace for 2 billion by end of year

Agreements to focus on driving adoption of AI and natural language processing for medical affairs programs

Virtually guided tests will be distributed to pharmacies across the country

The 130,000-square-foot site will be the CDMO's third location

Ten million doses expected by end of Q3

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

Latest report shows that air cargo demand has reached pre-Covid levels

Drone technology delivers doses to difficult-to-reach locations

In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production

Rivals will team up in order to accelerate supply

UK-based OXGENE designs and develops scalable gene therapy technologies

Purchase expands CRO's plans for cell and gene therapy program

Among the first pharmacies in the US to receive URAC Rare Disease Designation

Digital therapy tools link drug packaging with matching software—with aim of enhancing participant monitoring

Joins network of manufacturers contributing efforts to increase supply

Linkage to the company’s SensiWatch logistics-tracking technology is built-in

The latest people news happenings over the past month

Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts

Agency allows a stability budget of up to 2 weeks at -25°C

Joins UK consortium to help efficiently manufacture oral solid dosage medication

Deals provide Andlauer Healthcare Group full Skeleton Canada ownership and 49 percent stake in US branch

Country's Ministry of Public Health chooses cannabinoid pharma company as its medical supplier

Supply chain management and logistics company boosts its US presence

Company says it will be able to produce an estimated 12 million doses per month

Pair of agreements expands packaging company's international network